Cybin Inc
Change company Symbol lookup
Select an option...
CYBN Cybin Inc
EWA iShares MSCI Australia ETF
WDAY Workday Inc
BNOX Bionomics Ltd
NRDY Nerdy Inc
KEY KeyCorp
AMPX Amprius Technologies Inc
TPC Tutor Perini Corp
LTRN Lantern Pharma Inc
JGGC Jaguar Global Growth Corporation I
Go

Health Care : Pharmaceuticals | Small Cap Value
Based in Canada
Company profile

Cybin Inc. (Cybin) is a clinical-stage biopharmaceutical company. The Company is engaged in creating psychedelic-based therapeutics to address the unmet need for new treatment options for people who suffer from mental health conditions. Its development pipeline consists of deuterated psilocybin analog program (CYB003), deuterated dimethyltryptamine program (CYB004), phenethylamine derivatives program (CYB005), and technology programs. The Company is engaged in developing CYB003, a deuterated psilocybin analog for the treatment of major depressive disorder and CYB004, a deuterated DMT molecule for generalized anxiety disorder and has a research pipeline of investigational psychedelic-based compounds. The Company's CYB005 is focused on the development of therapeutic phenethylamine derivatives for the treatment of potential neuroinflammation and other neurological conditions. Cybin is operational in Canada, the United States, the United Kingdom, the Netherlands, and Ireland.

The symbol you entered, CLXPF, changed to CYBN.

Closing Price
$0.4884
Day's Change
-0.0589 (-10.76%)
Bid
--
Ask
--
B/A Size
--
Day's High
0.5417
Day's Low
0.4808
Volume
(Light)
Volume:
4,846,418

10-day average volume:
10,834,753
4,846,418
  • Prev Close
    0.5473
  • Today's Open
    0.5412
  • Day's Range
    0.4808-0.5417
  • Avg Vol (10-day)
    10.8M
  • Last (time)
    8:00p ET 09/28/23
  • Last (size)
    50
  • 52-Wk Range
    0.21 - 0.715
    LowHigh
  • (06/06/23 - 09/26/23)
    31.69%
  • 90.9%
  • Market Cap
    114.9M
  • Shares Outstanding
    235.2M
  • -0.25
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • --
  • 11.11
  • (% of float 09/15/23)
    2.57

Latest News

September 27, 2023
7:30 am ET
BusinessWire
September 26, 2023
7:30 am ET
BusinessWire
September 25, 2023
7:30 am ET
BusinessWire
September 21, 2023
5:00 pm ET
BusinessWire
7:30 am ET
BusinessWire
September 20, 2023
9:05 am ET
PR Newswire
September 19, 2023
8:02 am ET
PR Newswire
September 05, 2023
7:30 am ET
BusinessWire
August 28, 2023
1:23 pm ET
Newsfile
10:47 am ET
BusinessWire
August 23, 2023
9:37 pm ET
BusinessWire
August 17, 2023
7:30 am ET
BusinessWire
August 15, 2023
7:52 am ET
BusinessWire
August 14, 2023
7:30 am ET
BusinessWire
August 04, 2023
9:46 am ET
BusinessWire
August 02, 2023
7:30 am ET
BusinessWire
August 01, 2023
9:32 am ET
BusinessWire
July 31, 2023
6:29 pm ET
BusinessWire
July 27, 2023
7:30 am ET
BusinessWire
July 26, 2023
8:45 am ET
PR Newswire
7:30 am ET
BusinessWire
July 24, 2023
7:55 am ET
PR Newswire
7:55 am ET
BusinessWire
July 20, 2023
5:01 pm ET
BusinessWire
8:02 am ET
BusinessWire
July 12, 2023
2:11 pm ET
BusinessWire
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2023 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2023. All rights reserved.